Chronic inflammation is the silent architect of countless modern diseases — from arthritis to cardiovascular dysfunction. While pharmaceuticals remain the frontline treatment, mineral based interventions are emerging as a compelling complementary approach.

Magnesium, zinc, and silica based compounds have shown anti inflammatory potential in recent clinical trials. Their mechanisms vary: some stabilise cell membranes, others modulate cytokine release, and some reduce oxidative stress.

"Minerals offer a gentler, more sustainable intervention," says rheumatologist Dr James O'Connell. "They don't replace pharmaceuticals, but they can reduce dependency on them."

Leeming & Co. has been studying mineral driven inflammation pathways for over a decade. Their findings suggest that bio activated minerals may help regulate NF-κB signalling — a key driver of chronic inflammation.

The medical community remains cautiously optimistic, but the trend is clear: minerals are stepping out of the supplement aisle and into clinical conversations.